Israeli Tech Stocks Raise $165 Million on Toronto TSX, Bypassing NASDAQ.
Toronto Stock Exchange woos firms as race for Israeli tech listings grows (Times of Israel).
Yossi Boker, head...
Innovus (INNV) New E-Commerce Store on Track for $3 million in Sales 2019.
Innovus Pharmaceuticals Announces that its Delta Prime Savings Club E-Commerce Marketplace is on Track for Annual Sales of Approximately $3 million...
My Size (MYSZ) Signs License Agreement With Penti for Smart Body Measurement Application MySizeID.
(In a country of 80 million people, there are a lot of women shopping for undies, hosiery,...
Ronen Luzon (MYSZ) Interviewed on ILTV With Emanuelle Kadosh.
LOOKING FOR AN APP TO SOLVE YOUR ONLINE SHOPPING PROBLEMS?
What if I told you - you no longer...
Short Squeeze Alert.
Internet Stock Review Adds Ebix (EBIX) $39 to Watch List. Short Squeeze Coming? Price Target $110.
World’s Largest Performance Apparel Co., Gearing up for MySize (MYSZ) Smart Body Measurement.
Founded in 1892, DeMoulin Bros. and Co. is the oldest and largest manufacturer of music performance group apparel...
Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase from Prior Quarter.
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter...
MySize (MYSZ) in Jerusalem Post.
Israeli Start-Up MySize Eases Retail's Online Returns Problems.
While the company launched its SizeUp application in late 2015,...
My Size (MYSZ) Provides Business Update and Reports Results for the Second Quarter of...
Reports successful deployment of MySizeID with leading global retailers and apparel companies
AIRPORT CITY, Israel, Aug. 9, 2019 /PRNewswire/...
Don’t Under Promise and Over Deliver. Just Deliver!
According to new research, there’s no payoff in going above and beyond. No more Mr. Nice Guy?
Few...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
